Source: New feed
Short-seller takes aim at Beverly biotech, sparking claims of 'fake news'
Boston Business Journal
The laboratory space at Cellceutix. CEO Leo Ehrlich was way of allowing too many photos,… more. Don Seiffert. A tiny beverly biotech is engaged in a nasty feud with an anonymous short-seller who claims its business is a sham, leading to accusations of ...
and more »
Stemline Therapeutics' SL-401 Phase 2 BPDCN Data Delivered Via Oral Presentation at ASCO; High Response Rates Demonstrated Across All Lines As Enrollment Proceeds
[at noodls] - June 4, 2016 NEW YORK, June 04, 2016 (GLOBE NEWSWIRE) -- Stemline…